Intracerebroventricular injection of fusaric acid attenuates the anorexia by glucagon-like, peptide-1 in the neonatal chick

Citation
T. Bungo et al., Intracerebroventricular injection of fusaric acid attenuates the anorexia by glucagon-like, peptide-1 in the neonatal chick, PHARM BIO B, 70(2-3), 2001, pp. 251-255
Citations number
26
Categorie Soggetti
Neurosciences & Behavoir
Journal title
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
ISSN journal
00913057 → ACNP
Volume
70
Issue
2-3
Year of publication
2001
Pages
251 - 255
Database
ISI
SICI code
0091-3057(200110/11)70:2-3<251:IIOFAA>2.0.ZU;2-Y
Abstract
It is known that central injection of glucagon-like peptide-1 (GLP-1) suppr esses feeding in rats and chicks, but the systems for GLP-1 are still open with special reference to the chick. The present study was done to determin e whether a noradrenergic mechanism contributes to the anorexigenic effect of GLP-1 on the neonatal chick. Central administration of norepinephrine (N E) suppressed food intake with narcolepsy as GLP-1 in chicks. However, in s pite of that dopamine (DA) did not affect food intake, coadministration of inhibitor of dopamine-beta -hydroxylase (DBH), fusaric acid (FA), attenuate d the suppressive effect of GLP-1 on feeding behavior. It is suggested that there may be the interactive relationships between GLP-1 and noradrenergic system in the neonatal chick. (C) 2001 Elsevier Science Inc. All rights re served.